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In 1968 during the Thirteenth International Congress of Genetics in Tokyo, 
Heinrich Malling and I presented evidence for chemical induction of specific locus 
mutation in cultured mammalian cells.'.* In the same meeting, Kao and Puck also 
reported the success of chemical mutagenesis in Chinese hamster Following 
those initial experiments, there was a period of consolidation, mostly devoted to the 
demonstration that the heritable variations under study did include true mutations. 
Evidence for mutation has now been obtained in a great number of cell systems. This 
evidence has taken several forms, including quantitative predictions of the effects of 
ploidy, the efficacy of known mutagens in the induction of cell variants, and, most 
convincingly, the direct demonstration in mutant cells of altered gene  product^.',^ 
Although we can take satisfaction from the conclusion that mutations can be 
experimentally induced and analyzed in cultured mammalian cells, certainly many 
important questions remain. In this presentation I shall attempt to provide the 
background on and introduce a series of questions, uncertainties, and investigative 
possibilities in  this field. 
The significant problems that persist in mammalian cell mutagenesis may be 
grouped into three overlapping areas of research: 
1. The investigation of basic mutational events that take place in mammalian 
cells. 
2. The development of methods for the quantitation of mutation induced in 
cultured mammalian cells. 
3. The application of these methods for the screening of environmental mutagens. 
For convenience of presentation, these areas will be covered in sequence. 
INVFSTIGATION OF BASIC MUTATIONAL EVENTS 
Mutation is much more than a chemical or configurational change in DNA; it is a 
biological process deeply enmeshed in the structural and biological complexities of the 
cell and modulated by both internal and external factors. We still know little about the 
causes of spontaneous mutations, but the experimental evidence leaves no doubt that 
mutations occur in replicating as well as nonreplicating genomes of both pro- and 
eukaryotes. Our knowledge of the origin and nature of induced mutations far outstrips 
that relating to spontaneous ones, because it is always easier to analyze processes that 
one can manipulate experimentally than naturally occurring ones. Nevertheless, the 
manifestation of primary DNA lesion to a substantial alteration in gene expression 
follows a complex process, which acts as a sieve that allows only a proportion of the 
DNA lesion to proceed toward the final product of a mutant clone. According to 
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Auerbach, the mutagenic process for induced mutations may include (1) penetration 
of the mutagen to DNA; (2) production of a premutational lesion; (3) death from 
unrepaired damage; (4) repair of lesion, restoring the normal gene; ( 5 )  fixation of the 
premutational lesion as a mutated gene; (6) formation of mutant cells; (7) death of 
mutant cells; and (8) formation of a clone of mutant cells.' Two steps in the mutagenic 
process, namely, the premutational lesion caused by mispairing and the misrepair of 
the lesion, are the most important and basic mutational mechanisms. Many of the 
enzymes of DNA replication and repair contribute to the fate of primary DNA lesions, 
and the specificity of these enzymes contributes to the diversity of the mutational 
response. 
Mutational responses in cultured mammalian cells can be measured at the DNA, 
protein, and phenotype levels. The entire way in which we think about genetic events, 
especially mutation, in mammalian cells may soon take on new meaning as the 
significance of introns and exons and genomic fluidity begins to be understood. These 
problems of understanding some of the most fundamental aspects of the structural 
organization of eukaryotic genes are exciting ones, especially in the promise of new 
recombinant DNA and nucleic acid sequencing techniques to aid in solving them. 
Studies of mutations of mammalian cells at the DNA level, as measured by either 
restriction analysis or nucleotide sequencing, are just the beginning. 
Mutation can also be identified and measured at the protein level. Methods for one- 
or two-dimensional gel electrophoresis have been developed that are potentially 
powerful tools for monitoring mutations both in human somatic cells, in vitro and in 
vivo, and in human populations. If a change in electrophoretic mobility or molecular 
weight of a protein is indicated, the protein or peptide may be isolated for determina- 
tion of amino acid composition and sequence. A specific mutation at the gene level may 
thus be inferred. 
The effect of spontaneous and induced mutations on the expression of hypoxan- 
thine guanine phosphoribosyltransferase (HPRT) (resistance to the analogues of the 
purine bases) in cultured mammalian somatic cells has been studied extensively. 
Several investigators have reported abnormalities in the immunochemical, catalytic, 
and electrophoretic properties of the enzyme in mutagenized HPRT-deficient cell lines 
and their revertants (reviewed in Reference 8). Alterations in peptide maps of the 
enzyme have been detected in several variant cell lines."' These studies provide 
evidence for the existence of a variety of undefined mutations in the structural gene for 
HPRT in cultured mammalian cells. 
In man, an inherited deficiency of HPRT is associated with two distinct clinical 
syndromes: a virtually complete deficiency of HPRT activity has been described in 
patients with Lesch-Nyhan syndrome, while a partial enzyme deficiency is found in 
some male patients presenting with hyperuricemia and a severe form of gout. Human 
HPRT exists, in its native state, as a tetramer of identical subunits, coded by a single 
X-linked gene locu~ . '~  The complete amino acid sequence of HPRT from human 
erythrocytes has been defined.I3 Each subunit of the enzyme is 217 amino acids long 
with a molecular weight equal to 24,470. Jolly et al. recently reported the isolation and 
preliminary characterization of cloned cDNA sequences of the human HPRT gene." 
The amino acid sequence predicted from the nucleotide sequence of the cDNA is in 
complete agreement with that defined by protein sequencing except that the NHz 
terminal methionine coded for by the initiator codon is absent in the mature enzyme. 
More recently, the molecular basis for HPRT deficiency in two unrelated gout 
patients has been defined as single amino acid substitutions.'s*16 One enzyme variant, 
called HPRT-., has a serine-to-leucine substitution at position 109. This substitu- 
tion can be explained by a single nucleotide change in the codon for serine (UCA - 
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UUA). Sequence analysis of a single peptide in the variant enzyme (HPRT,,,,,,,) of 
another gout patient revealed an arginine-to-glycine amino acid substitution at  
position 50 (codon for Arg,, changed from CGA to GGA). These significant 
developments not only demonstrate for the first time the molecular basis of human 
mutation at the HPRT locus but also suggest the feasibility of identifying the 
molecular defects of HPRT mutants, spontaneous and induced, that can be obtained in 
cultured human cells. 
The most prevailing end point for assessing mutations in cultured mammalian cells 
is a change in the cellular phenotype, such as nutritional requirement, resistance to 
cytotoxic agents, or cell membrane alterations. At this level, it is particularly 
important to distinguish the nature of somatic variations arising in vifro, whether it is 
genetic or epigenetic. Recently, Morgan Harris showed that brief exposure of 
5-bromodeoxyuridine-tolerant, thymidine kinasedeficient (TK-) Chinese hamster 
cells to 5-azacytidine resulted in massive conversion to the HAT+ state (ability to grow 
in medium containing hypoxanthine, aminopterin, and thymidine),” suggesting that 
the induction of revertants might have resulted from changes in DNA methylation 
patterns. Similarly, 5-azacytidine treatment has been used to reactivate the expression 
of the HPRT gene on the inactive X chromosome in Chinese hamster cells.” 
Even though the change is genetic, an alteration in the phenotype could be the 
result of either a genic or chromosomal event. ‘For instance, Cox and Masson have 
shown that x-ray-induced mutations to 6-thioguanine resistance in cultured human 
diploid fibroblasts consist mostly of chromosomal deletions or rearrangements.” 
Hozier and his associates have made a cytogenetic analysis of the L5178Y/TK+/- - 
TK-’- mouse lymphoma mutagenesis assay system.20 Mutant TK-/-  colonies form a 
bimodal frequency distribution of colony sizes for most mutagenic or carcinogenic test 
substances. Large-colony TK-/- mutants with normal growth kinetics appear karyo- 
logically identical within and among clones and with the T K + / -  parental cells. In 
contrast, most slow-growing, small-colony TK-/- mutants have a readily recognizable 
chromosome rearrangement involving the mouse chromosome 1 1  on which the TK 
locus is located. 
Cell lines have been developed in which point mutation, chromosome loss, or 
chromosome deletion leading to the disappearance of a phenotype could be directly 
assayed. Puck has developed a test system in which the marker is contained on a 
chromosome not itself necessary for cell reproduction.2’ One such example is a reduced 
human-Chinese hamster cell hybrid in which a single human chromosome 1 1  is 
retained and mutations at  several loci on this chromosome, namely, the antigenic 
markers a , ,  a2, a,, LDH-A, and AcP-2, can be induced with mutagens. Any possible 
modification of a human protein or enzyme and the presence or absence of chromo- 
some 1 1  or its segment can be studied. Using two-dimensional gel electrophoresis, a t  
least eight distinct spots unique to the cell containing chromosome 1 1  have been 
located on the electrophoretogram.22 
DEVELOPMENT OF METHODS FOR QUANTITATION OF MUTATION 
INDUCTION IN CULTURED MAMMALIAN CELLS 
Choice of Cell Marerial 
A general question regarding any study of cultured cells is whether it accurately 
reflects the cellular responses in the intact animal. This point may be addressed using 
the direct-acting mutagen testing systems in which peripheral lymphocytes in the 
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intact animal are ,examined. Another question is, Can the results derived with rodent 
cells be extended to the cells of humans? There is evidence that the repair of DNA 
damage differs both in process and extent between human and rodent cells.23 Clearly, 
our knowledge of the similarities and differences in DNA replication and repair of 
human and other mammalian cells is lacking because of the dearth of human cell 
mutants for these fundamental processes. Therefore, studies of mutagenesis with 
human diploid fibroblasts, lymphoblastoid cell lines, or other established near-diploid 
cell lines should reduce the necessity for extrapolation to man. 
Development of Selectable Genetic Markers 
On the basis of classical studies with corn and Drosophila, the rates of spontaneous 
mutation may differ among different loci. Evidence has been presented that in certain 
mutator strains of Chinese hamster ovary (CHO) cells, the spontaneous mutation rates 
were 5- to 50-fold higher than those in parental cells for two genetic markers 
(resistance to 6-thioguanine or to ouabain), but the rates for two other markers 
(reversion of proline auxotrophy to prototrophy and forward mutation to emetine 
resistance) were unaffected.24 As shown by several investigators, certain agents such as 
x-rays and gamma-rays fail to induce ouabain-resistant mutants in mammalian 
 cell^,*^-^^ although they are capable of inducing 6-thioguanine-resistant mutants in the 
same cell type. Therefore, it appears that mutation rates may be site specific for 
mammalian cells as well. From both the theoretical and practical points of view, one of 
the important tasks is to develop additional selectable genetic markers for comparative 
mutagenesis among loci and for more accurate assessment of mutagenic potential of 
environmental chemicals. 
Metabolic Activation 
Environmental chemical mutagens often are nonreactive and have to be enzymati- 
cally activated before they can manifest their biological effects. Many cell types, 
including CHO and mouse lymphoma L5178Y cells, are not capable of activating 
procarcinogens or promutagens. Mutagenesis in these cells has to be studied by the 
addition of enzymatically active liver subcellular fraction, or by cocultivation with 
intact hepatocytes (cell-mediated mutagenesis). Tong and Williams have developed a 
system in which adult rat liver epithelial cells are used to detect genotoxic compounds 
by mutations at the HPRT locus.28 
The subcellular enzyme fractions, such as rat liver microsomal S-9 fractions, are 
simpler to use and have been shown to activate a wide variety of procarcinogens. 
However, it has been shown that the profile of the metabolites and DNA adducts 
formed after metabolism of various potent carcinogens is different from that of intact 
cells. This indicates that the use of subcellular fractions does not accurately simulate 
the in vivo situation. It is also known that for certain classes of chemicals, metabolic 
activation or inactivation is species specific. If it can be metabolically activated in 
vitro, will it also be activated in humans? The major dilemma here is that given a 
chemical about which little is known, it is difficult to ensure that the activation system 
used will detect its possible mutagenic potential. Furthermore, the concentration of the 
S-9 fraction used in the cell-mutagenesis experiments may affect cell viability, thus 
introducing another source of biological variability to quantitative mutagenesis. 
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Phenotypic Expression 
The course of events from the initial mutagenic insult to a cell to the appearance of 
the cell’s progeny as a mutant colony is complicated and largely undefined. The 
so-called phenotypic expression refers to this series of unknown processes leading to the 
eventual recognition of the mutant. Forward mutations, such as HPRT- or TK-,  
which represents a loss of function, could be the result of a spectrum of mutational 
events including chromosome loss, chromosomal deletion, nucleotide base substitution, 
and base addition or deletion (frameshift changes). The lesion, such as a loss or change 
of a base, could be repaired without error, thus producing no mutation, or could be 
misrepaired, leading to a change (mutation) in the normal nucleotide sequence. In 
theory, two rounds of cell replication are needed for “error replication” resulting in an 
altered base pair. Furthermore, cell divisions are necessary to allow dilution or 
degradation of the parental mRNA and/or enzyme in the cell carrying the mutated 
gene. These are the reasons why a period of phenotypic expression between the removal 
of the mutagen and the addition of the selective agent is necessary. The length of this 
period has been experimentally determined for a maximum recovery of the HPRT- 
and TK- mutations, and different lengths of time have been shown for mutants a t  
other loci. 
For both test systems using CHO or L5178Y cells, a predetermined period for 
phenotypic expression is allowed. Li devised a simple technique for growth of CHO 
cells as unattached cultures.29 The optimum expression time was shorter for 
unattached cells (six days) than for attached cells (nine days). However, it is 
conceivable that different newly arisen mutants may have different growth rates and 
different selective advantages, relative to each other and to the parental cells. Some 
mutants may have divided more frequently than the parental cells and are  overrepre- 
sented; others may be very slow growers, which may be missed in an enumeration of 
mutant colonies a t  a fixed time. Still other mutants may not thrive at  all. Using the 
respreading technique, the mutation frequency is therefore only an average estimate. 
Cell Density (Metabolic Cooperation) 
Another factor that may affect mutation frequency is cell density. It was shown, 
especially in the case of HPRT- mutant selection, that intercellular communication 
upon contact will diminish the number of mutants recovered. This phenomenon, known 
as “metabolic cooperation,” occurs during 6-thioguanine selection and entails a 
transfer of metabolites, such as 6-thioguanosine monophosphate, through the gap 
junctions on the cell membrane from the dying parental cells to mutants, killing the 
latter in the process. For CHO cells, reconstruction experiments have determined the 
maximum cell density (2 x 105/10 cm dish) that would not affect HPRT- mutant 
frequency. 
The problem of metabolic cooperation may be less serious in L5 178Y cells grown in 
suspension due to a small number of gap junctions on the cell surface. Metabolic 
cooperation may also be reduced or abolished in the presence of tumor promoters (P. 
Liu, personal communication). For certain membrane markers, such as resistance to 
ouabain or a b r i ~ ~ , ~ ’  there was no demonstrable metabolic cooperation. For still other 
genetic markers under different situations, cross feeding in crowded cultures may 
actually increase, rather than decrease, the mutation frequency. Harris showed that 
the incidence of spontaneous variation to puromycin resistance in pig kidney cells 
increased in proportion to population den~i ty .~’  Large colonies or aggregates of 
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sensitive cells grew progressively in puromycin at concentrations that destroyed the 
same populations completely when present in dispersed form. Harris concluded that 
response to puromycin is conditioned by cellular interactions as well as by genetic 
susceptibility. 
Back Mutation and Preexisting Mutants 
It is generally assumed that there is no back mutation during the course of 
mutagenicity testing, but this possibility needs to be verified. If it does indeed occur, 
the frequency should be accounted for in an estimate of the spontaneous and induced 
forward mutations. 
The existence of preexisting mutants of spontaneous origin may be troublesome in 
the evaluation of a weak mutagen. There are experimental procedures, however, such 
as recloning or pregrowth in counterselective media, to eliminate or reduce the number 
of preexisting mutants in cell populations prior to mutagenicity testing. 
Effects at Low Doses 
At very low doses of chemicals, the linearity of dose-effect curves has not been 
settled. In both CHO and the mouse lymphoma cell systems, dose-effect relationships 
within a certain range of concentrations have been obtained for many chemicals, such 
as ethyl methanesulfonate and ethyl nitrosourea. However, it is debatable whether a 
linear extrapolation to lower doses is either reasonable or desirable. 
A number of biological factors may play important roles during the entry of a 
chemical (or its derivatives) into the cell and the nucleus before its interaction with the 
genetic material. The question in a testing situation is to find the lowest effective dose 
that can induce mutation, not the theoretical threshold. The practical problem is the 
chronic exposure to low doses, rather than the demonstration of mutation induction 
after a single acute exposure at a very low dose. It seems that a dose-response curve 
using a series of doses is more informative than the determination of a “doubling dose” 
of the spontaneous frequency. 
APPLICATION OF MAMMALIAN CELL MUTATION ASSAY SYSTEMS FOR THE 
SCREENING OF ENVIRONMENTAL MUTAGENS 
Choice of Test Systems 
Numerous cell lines, markers, and selective systems are now available. The use of 
human versus nonhuman somatic cells in cultures for mutation assay may be 
considered on the basis of technical advantages and relevance to man. The extent to 
which the assays could or should be used is a matter of controversy. Some people may 
feel that the assays are functional and the available systems should now be employed as 
far as practicable in the process of hazard evaluation. To wait for the ideal system is, in 
fact, a decision to continue to expose people and the environment to chemicals of 
unknown activity. At the Banbury conference in 1979, the weight of opinion was that 
the present test systems used in conjunction with various other end points are better 
than nothing. It was considered better to have a few false positives and negatives rather 
than exposure to a whole lot of potentially hazardous chemicals. 
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Definition of Basic Parameters of a Mutagen Screening System 
Many factors must be examined to distinguish between genetic and epigenetic 
events, and certain basic criteria must be met if one claims to have a true mutational 
system. The types of mutation that are measured, whether genic, chromosomal, or 
both, should be delineated. In fact, for screening of mutagenicity of environmental 
chemicals, forward mutations-which encompass a broad spectrum of mutational 
events-may be preferable to reverse mutations. On the other hand, reverse mutations 
can help to identify the mutagenic specificity of chemicals. 
The fact that many have developed reliable mutation systems does not imply that 
the work is easy or without problems. Many problems must be addressed for each 
system. Laboratories adopting a system should standardize the assay conditions and 
demonstrate that consistent, reproducible results can be obtained. The use of positive 
and solvent controls, the use of appropriate activation systems, background mutation 
frequencies consistent with historical controls, dose-response curves, and other baseline 
information should be defined. It may also be helpful to establish the classes of 
carcinogens and mutagens that the system accurately detects. 
Increase in the Mutability of Cells 
Recent years have witnessed a sharply increased number of studies of mutator and 
antimutator mutations in a variety of organisms, the most penetrating analyses being 
conducted in prokaryotes and fungi. These studies have proceeded in parallel with 
analyses of mechanisms of DNA replication and repair, a t  the same time as genes 
responsible for these functions have been identified by conditional lethal and/or 
mutagen-sensitive mutations. 
In mammalian cells, increased rates of spontaneous mutations have been demon- 
strated in mutator strains that have modified intracellular nucleoside triphosphate 
pls.24.32.33 In addition to cell strains obtained from the repair-defective human 
syndromes, several laboratories have reported the isolation of mutants in cultured 
rodent cells that have increased sensitivity to killing by mutagens, such as ultraviolet 
(UV) light (e.g., References 34-36). In some of these UV-sensitive mutants, enhance- 
ment of UV mutagenic response has been dem~nstrated.~’ Conceivably, these and 
other hypermutable cell strains will be very useful in increasing the sensitivity for 
detecting certain classes of mutagens. It is of particular importance to obtain human 
cell mutants defective in DNA repair for such purposes. 
Statistical Analysis 
In quantitative measurements of cell survival and mutation frequency, there are a 
number of sources of errors that affect the final mutant yield, including cell counts, cell 
viability during cytotoxicity tests, growth rate, and competition among the newly 
arisen mutants. Appropriate statistical models to account for these sources of 
variability and the choice of statistical methods for the analysis of data are important 
considerations in screening tests of environmental mutagens and carcinogens. There 
seem to be many valid problems in this area that require further research and 
discussion. A workshop on statistical analysis of in vitro tests for mutagenicity was held 
in April 1981 in Chapel Hill, North Carolina, under the joint sponsorship of the 
National Institute of Environmental Health Sciences and the National Toxicology 
Program. A report of the workshop will be published. 
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SUMMARY 
Experimental studies on the complex process of mutagenesis are conducted in the 
belief that they will increase our understanding of the effects of environmental agents 
on human populations. Cultured mammalian cells offer distinct advantages over other 
biological systems for studying this problem. Mutagenesis in cultured mammalian cells 
is unquestionably more relevant to man than are bacterial, fungal, or insect systems. At 
the same time, compared to whole-animal studies, cultured cells offer the advantage of 
ease of handling, low cost, and rapidity of assay.’* 
Mutation in cultured mammalian cells can be identified and measured at the 
phenotypic, protein, and DNA levels. Test systems have been developed to detect both 
gene and chromosome mutations. Direct evidence is available for true mutations 
occurring in mammalian cells, although some of the heritable variations could be 
epigenetic. It is now possible to identify the specific molecular alternations in 
mammalian cell mutants arising in vitro. 
The development of methods for the quantitation of mutation in cultured mamma- 
lian cells has been briefly considered in this presentation, particularly with reference to 
the choice of cell material, development of selective markers, and the various factors 
that affect quantitative measurement of mutations. Although notable progress has 
been made, much still remains to be learned to make these measurements more 
reliable. 
In applying the mammalian cell mutation assays for the screening of environ- 
mental mutagens, the choice of a system or systems should be based on their technical 
advantages and relevance to man. The basic parameters of the mutagen screening 
system must be well defined and controlled. The sensitivity for detection may be 
increased by the use of hypermutable cell strains. Appropriate statistical models to 
account for various sources of variability and the choice of statistical methods for the 
analysis of data are important considerations in screening environmental mutagens 
and carcinogens. 
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